News

Nurse Practitioner - Queenstown Queenstown Medical Centre has been part of the local community for more than 50 years. We’re proud of the trusted relationships we’ve built, within our team, with our patients, and across our wider community. With three practices located in Queenstown, Frankton, and Jacks Point, we offer a full range of primary care services, with urgent care provided from our Queenstown site. The Role We’re looking for an experienced NP who’s passionate about delivering...

We’re seeking Nurse Practitioners for contract roles across Auckland to provide weekly rounds to Aged Residential Care (ARC) facilities, delivering high-quality care to older patients with complex needs. Join us in Auckland, the City of Sails, where you’ll enjoy the autonomy of working in aged residential care, flexible contract opportunities, and the lifestyle benefits of a vibrant harbour city with beautiful beaches, diverse communities, and an outstanding work-life balance. You will...

These key messages, identified by Gout Action Aotearoa, a group of clinicians, researchers and organisations with a focus on improving the treatment and management of gout, are helpful when discussing gout with your patient and their whānau: Gout is not your fault. Gout is caused by too much uric acid in your body. The uric acid forms crystals in your joints, causing painful gout attacks. 90% of the uric acid in your body is caused by your genes and kidneys, while only 10% is caused by food...

Pharmac has decided to widen access to four funded medicines for people with type 2 diabetes: empagliflozin, empagliflozin with metformin, liraglutide and dulaglutide, from 1 September 2026. The medicines are already funded. The new eligibility criteria will allow people with type 2 diabetes, whose blood sugar levels remain high despite treatment with other funded diabetes medicines, to access these treatments. This change applies to empagliflozin, empagliflozin with metformin, liraglutide...

From 1 October 2026, the statin rosuvastatin will no longer require a Special Authority for funded access. This means it will be open listed and may be prescribed as a funded medicine to any New Zealander where clinically appropriate. You can read the notification on the Pharmac website here Please share this information: Please share this information with your colleagues and within your networks. If you have any questions regarding this supply issue, please contact enquiry@pharmac.govt.nz....

Below is the latest information on Pharmac consultations, notifications, and supply issues for Primary Care Prescribers for week 31 July 2026. It includes information on: New updates Resolved Supply Issues New updates: Coversyl tablets change of salt: Perindopril erbumine to Perindopril arginine Due to global alignment and to ensure continuity of supply, Coversyl containing perindopril erbumine will be replaced with Coversyl containing perindopril arginine. The new Perindopril arginine...